Online marketing for compounded GLP-1 drugs overstates benefits and underplays risks
Dozens of sites mislead patients by suggesting compounded obesity drugs were approved by the FDA
In Connecticut, where Medicaid has clamped down on covering GLP-1 medications for obesity, people are looking for alternatives. To make ends meet, some of Reshma Ramachandran's patients at a federally qualified health center in New Haven have turned to cash-pay, compounded versions of the drugs.
But they're sometimes confused about what they're getting. Patients who obtain compounded GLP-1s online sometimes come into visits thinking their medications are approved by the Food and Drug Administration, said Ramachandran, a physician and health services researcher at the Yale School of Medicine. "Yes, the laboratory might be registered or might be known to the FDA," she'll explain. "But the actual drugs themselves are not tested by the FDA beforehand."GLP=G
www.statnews.com
Dozens of sites mislead patients by suggesting compounded obesity drugs were approved by the FDA
In Connecticut, where Medicaid has clamped down on covering GLP-1 medications for obesity, people are looking for alternatives. To make ends meet, some of Reshma Ramachandran's patients at a federally qualified health center in New Haven have turned to cash-pay, compounded versions of the drugs.
But they're sometimes confused about what they're getting. Patients who obtain compounded GLP-1s online sometimes come into visits thinking their medications are approved by the Food and Drug Administration, said Ramachandran, a physician and health services researcher at the Yale School of Medicine. "Yes, the laboratory might be registered or might be known to the FDA," she'll explain. "But the actual drugs themselves are not tested by the FDA beforehand."GLP=G

Online marketing for compounded GLP-1 drugs overstates benefits and underplays risks
A new analysis finds nearly half of the compounded GLP-1 websites didn’t include information on adverse effects, warnings, contraindications.
